The company previously booked 64 to 85 of software sale upfront, spreading the rest over the remainder of the agreement period. Our problem with Accelrys was investors did not have visibility.

on Remember, stocks will continue to advise you to invest in businesses for the longrun, not to trade positions for days and months. At 19. 98 per share, FEIC trades at just over times projected revenue of 475 million. company trading at times its trailing 12months earnings might seem expensive for value investors, but it obscures its scalable business model. SG Cowen analyst Phil Nadeau says, The accounting change is good thing. FEI was scheduled to report its Q3 earnings on Click here to download Josh Wolfes mustread primer on the exciting new science of nanotechnology.

The markets have been discounting both stocks in the past several months on the expectation of softness in the semiconductor equipment market. SG Cowen analyst Phil Nadeau says, The accounting change is good thing. And therein lies the opportunity for nanotechnology investors. 30, 2004 alone comprise more than 47 of ACCLs 139. 97 million market capitalization. The year started out on high note after President George The company previously booked 64 to 85 of software sale upfront, spreading the rest over the remainder of the agreement period.

This should take away some of the surprise and volatility. The key takehome for investors is that following next quarter ending 31, 2005. More Adviser Soapboxes Send comments and questions to newslettersforbes. com. Following the Nanosys postponement, many nanotech companies have been struggling to reinvent themselves to remove any appearance that they were nanopretenders. Bush signed 3. 7 billion nanotech bill.

Wall Street analysts project FEI will earn 0. 85 per share in profit each year. We have already devoted great deal of ink to NVE, so if you missed any of it, please consult our archives. Click here to download Josh Wolfes mustread primer on the exciting new science of nanotechnology. Emkjer introduced subscription accounting to create smoother sales cycle and focused ACCL on nanotechnology by introducing the Accelrys Nanotechnology Consortium. Its been said that new technologies are almost always overestimated in the shortrun, but underestimated over the longrun.